Proopiomelanocortin-Derived Peptides and Their Receptors in the Immune System

  • Kenneth L. Bost
  • Eric M. Smith
  • J. Edwin Blalock
Part of the GWUMC Department of Biochemistry Annual Spring Symposia book series (GWUN)


It has been known for many years that stressful situations can be a contributing factor in the development of a variety of bacterial, viral, and neoplastic diseases (Riley, 1981; Stein, 1985). Specifically, decreased immunocompetence seems to account for the increased susceptibility of stressed hosts for these disease states. An increasing interest in the biochemical basis for this stress-induced immune suppression has resulted in the emergence of a new discipline (Holden, 1980). This field has been referred to as psychoimmunology, neuroimmunoendocrinology, neu-roimmunomodulation, and behavioral medicine. Regardless of the title given to this new field, the question being addressed is the same: How are the nervous, endocrine, and immune systems interrelated?


Vasoactive Intestinal Peptide Vasoactive Intestinal Polypeptide Opiate Receptor Adrenal Cell Mononuclear Leukocyte 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ader, R., ed., 1981, Psychoneuroimmunology, Academic Press, New York.Google Scholar
  2. Bar-Shavit, Z., Terry, S., Blumberg, S., and Goldman, R., 1982, Neurotensin-macrophage interaction: Specific binding and augmentation of phagocytosis, Neuropeptides 2:325–335.CrossRefGoogle Scholar
  3. Beed, E. A., O’Dorisio, S., O’Dorisio, T. M., and Gaginella, T. S., 1983, Demonstration of a functional receptor for vasoactive intestinal polypeptide on Molt 4b T lymphoblasts, Regul. Peptides 6:1–12.CrossRefGoogle Scholar
  4. Blalock, J. E., 1984a, Relationships between neuroendocrine hormones and lymphokines, Lymphokines 9:1–13.Google Scholar
  5. Blalock, J. E., 1984b, The immune system as a sensory organ, J. Immunol. 132:1067–1070.PubMedGoogle Scholar
  6. Blalock, J. E., and Smith, E. M., 1985, A complete regulatory loop between the immune and neu-roendocrine systems, Fed. Proc. 44:108–111.PubMedGoogle Scholar
  7. Blalock, J. E., Johnson, H. M., Smith, E. M., and Torres, B. A., 1985, Enhancement of the in vitro antibody response by thyrotropin, Biochem. Biophys. Res. Commun. 125:30–34.CrossRefGoogle Scholar
  8. Bohs, C. T., Fish, J. C., Miller, T. H., and Traber, D. L., 1979, Pulmonary vascular response to endotoxin in normal and lymphocyte depleted sheep, Circ. Shock 6:13–21.PubMedGoogle Scholar
  9. Bost, K. L., Smith, E. M., and Blalock, J. E., 1985, Similarity between the corticotropin (ACTH) receptor and a peptide encoded by an RNA that is complementary to ACTH mRNA, Proc. Natl. Acad. Sci. U.S.A. 82:1372–1375.PubMedCrossRefGoogle Scholar
  10. Brooks, W. H., Cross, R. J., Roszman, T. L., and Markesbery, W. R., 1982, Neuroimmunomodulation: Neural anatomical basis for impairment and facilitation, Ann. Neurol. 12:56–61.PubMedCrossRefGoogle Scholar
  11. Carr, D. B., Bergland, R., Hamilton, A., Blume, H., Kasting, N., Arnold, M., Martin, M. B., and Rosenblatt, M., 1982, Endotoxin stimulated opioid peptide secretion: Two secretory pools and feedback control in vivo, Science 217:845–848.PubMedCrossRefGoogle Scholar
  12. Cross, R. J., Markesbery, W. R., Brooks, W. H., and Roszman, T. L., 1980, Hypothalamic-immune interactions. I. The acute effect of anterior hypothalamic lesions on the immune response, Brain Res. 196:79–87.PubMedCrossRefGoogle Scholar
  13. Cutz, E., Chan, W., Track, N., Goth, A., and Said, S., 1978, Release of vasoactive intestinal peptide in mast cells by histamine liberators, Nature 275:661–662.PubMedCrossRefGoogle Scholar
  14. Danek, A., O’Dorisio, M. S., O’Dorisio, T. M., and George, J. M., 1983, Specific binding sites for vasoactive intestinal polypeptide on nonadherent peripheral blood lymphocytes, J. Immunol. 131:1173–1177.PubMedGoogle Scholar
  15. Dupont, A. G., Somers, G., Van Steirteghen, A. C., Warson, F., and Vanhaelst, L., 1984, Ectopic adrenocorticotropin production: Disappearance after removal of inflammatory tissue, J. Clin. En-docrinol. Metab. 58:654–658.CrossRefGoogle Scholar
  16. Faith, R. E., Plotnikoff, N. P., and Murgo, A. J., 1986, Effects of opiates and enkephaline-endorphins on immune functions, in: Proceedings, National Institute of Drug Abuse Technical Meeting on Mechanisms of Tolerance and Dependence (in press).Google Scholar
  17. Giachetti, A., Goth, A., and Said, S. I., 1978, Vasoactive intestinal polypeptide (VIP) in rabbit platelets and rat mast cells, Fed. Proc. 37:657.Google Scholar
  18. Gilman, S. C., Schwartz, J. M., Milner, R. J., Bloom, F. E., and Feldman, J. D., 1982, β-Endorphin enhances lymphocyte proliferative responses, Proc. Natl. Acad. Sci. U.S.A. 79:4226–4230.PubMedCrossRefGoogle Scholar
  19. Goldstein, M. M., 1978, Antibody-forming cells of the rat spleen after injury to the midbrain, Bull. Exp. Biol. Med. 82:183–187.CrossRefGoogle Scholar
  20. Harbour-McMenamin, D. V., Smith, E. M., and Blalock, J. E., 1985, Bacterial lipopolysaccharide induction of leukocyte derived ACTH and endorphins, Infect. Immun. 48:813–817.PubMedGoogle Scholar
  21. Hazum, E., Chang, K., and Cuatrecasas, P., 1979, Specific nonopiate receptors for β-endorphin, Science 205:1033–1035.PubMedCrossRefGoogle Scholar
  22. Heldin, C. H., and Westermark, B., 1984, Growth factors: Mechanism of action and relation to oncogenes, Cell 37:9–20.PubMedCrossRefGoogle Scholar
  23. Holaday, J. W., and Faden, A. I., 1978, Naloxone reversal of endotoxin hypotension suggests role of endorphin in shock, Nature 275:450–451.PubMedCrossRefGoogle Scholar
  24. Holden, C., 1980, Behavioral medicine: An emergent field, Science 209:479–481.PubMedCrossRefGoogle Scholar
  25. Jankovic, B. D., and Isakovic, K., 1973, Neuroendocrine correlates of immune response, Int. Arch. Allergy Appl. Immunol. 45:360–372.PubMedCrossRefGoogle Scholar
  26. Johnson, H. M., Smith, E. M., Torres, B. A., and Blalock, J. E., 1982, Neuroendocrine hormone regulation of in vitro antibody production, Proc. Natl. Acad. Sci. U.S.A. 79:4171–4174.PubMedCrossRefGoogle Scholar
  27. Johnson, H. M., Torres, B. A., Smith, E. M., Dion, L. D., and Blalock, J. E., 1984, Regulation of lymphokine (7-interferon) production by corticotropin, J. Immunol. 132:246–250.PubMedGoogle Scholar
  28. Kay, N., Allen, J., and Morley, J. E., 1984, Endorphins stimulate normal human peripheral blood lymphocyte natural killer activity, Life Sci. 35:53–59.PubMedCrossRefGoogle Scholar
  29. Krieger, D. T., 1983, Brain peptides: What, where and why? Science 222:975–985.PubMedCrossRefGoogle Scholar
  30. Lolait, S. J., Lim, A. T. W., Toh, B. H., and Funder, J. W., 1984, Immunoreactive β-endorphin in a subpopulation of mouse spleen macrophages, J. Clin. Invest. 73:277–280.PubMedCrossRefGoogle Scholar
  31. Lopker, A., Abood, L. G., Hoss, W., and Lionetti, F. J., 1980, Stereoselective muscarinic acetylcholine and opiate receptors in human phagocytic leukocytes, Biochem. Pharmacol. 29:1361–1365.PubMedCrossRefGoogle Scholar
  32. Lygren, I., Revhaug, A., Burhol, P. G., Giercksky, K. E., and Jenssen, T. G., 1984, Vasoactive intestinal peptide and somatostatin in leukocytes, Scand. J. Clin. Lab. Invest. 44:347–351.PubMedCrossRefGoogle Scholar
  33. Macris, N. T., Schiavi, R. C., Camerino, M. S., and Stein, M., 1970, Effects of hypothalamic lesions on immune processes in the guinea pig. Am. J. Physiol. 219:1205–1209.PubMedGoogle Scholar
  34. Mathews, P. M., Droelich, C. J., Sibbitt, W. L., Jr., and Bankhurst, A. D., 1983, Enhancement of natural cytotoxicity by β-endorphin, J. Immunol. 130:1658–1662.PubMedGoogle Scholar
  35. McCain, H. W., Lamster, I. B., Bozzone, J. M., and Grbic, J. T., 1982, β-endorphin modulates human immune activity via non-opiate receptor mechanisms, Life Sci. 31:1619–1624.PubMedCrossRefGoogle Scholar
  36. Mcllhinney, R. A. J., and Schulster, D., 1975, Studies on the binding of 125I-labelled corticotropin to isolated rat adrenocortical cells, J. Endocrinol. 64:175–184.CrossRefGoogle Scholar
  37. Mehrishi, J. N., and Mills, I. H., 1983, Opiate receptors on lymphocytes and platelets in man, Clin. Immunol. Immunopathol. 27:240–249.PubMedCrossRefGoogle Scholar
  38. Nakanishi, S., Inoue, A., Kita, T., Nakamura, M., Chang, A. C. Y., Cohen, S. N., and Numa, S., 1979, Nucleotide sequence of cloned cDNA for bovine corticotropin-β-lipotropin precursor, Nature 278:423–427.PubMedCrossRefGoogle Scholar
  39. O’Dorisio, M. S., O’Dorisio, T. M., Cataland, S., and Balcerzak, S. P., 1980, Vasoactive intestinal peptide as a biochemical marker for polymorphonuclear leukocytes, J. Lab. Clin. Med. 96:666–670.PubMedGoogle Scholar
  40. Ottaway, C. A., and Greenburg, G. R., 1984, Interaction of vasoactive intestinal peptide with mouse lymphocytes, J. Immunol. 132:417–423.PubMedGoogle Scholar
  41. Ottaway, C. A., Bernaerts, C., Chan, B., and Greenberg, G. R., 1983, Specific binding of vasoactive intestinal peptide to human circulating mononuclear cells, Can. J. Physiol. Pharmacol. 61:664–671.PubMedCrossRefGoogle Scholar
  42. Payan, D. G., Brewster, D. R., and Goetzl, E. J., 1983, Specific stimulation of human T lymphocytes by substance P, J. Immunol. 131:1613–1615.PubMedGoogle Scholar
  43. Payan, D. G., Brewster, D. R., and Goetzl, E. J., 1984a, Stereospecific receptors for substance P on cultured human IM-9 lymphoblasts, J. Immunol. 133:3260–3265.PubMedGoogle Scholar
  44. Payan, D. G., Hess, C. A., and Goetzl, E. J., 1984b, Inhibition of somatostatin of the proliferation of T-lymphocytes and Molt-4 lymphoblasts, Cell. Immunol. 84:433–438.PubMedCrossRefGoogle Scholar
  45. Plotnikoff, N., and Miller, G. C., 1983, Enkephalins as immunomodulators, Int. J. Immunopharmacol. 5:437–441.PubMedCrossRefGoogle Scholar
  46. Reynolds, D. G., Guill, N. V., Vargish, T., Hechner, R. B., Fader, A. I., and Holaday, J. W., 1980, Blockade of opiate receptors with naloxone improves survival and cardiac performance in canine endotoxic shock, Circ. Shock 7:39–48.PubMedGoogle Scholar
  47. Riley, V., 1981, Psychoneuroendocrine influences on immunocompetence and neoplasia, Science 212:1100–1109.PubMedCrossRefGoogle Scholar
  48. Siegel, H. S., Gould, N. R., and Lattimer, J. W., 1985, Splenic leukocytes from chickens injected with Salmonella pullorum antigen stimulate production of corticosteroids by isolated adrenal cells, Soc. Exp. Biol. Med. 178:523–530.Google Scholar
  49. Simon, E. J., and Miller, J. M., 1981, Opioid peptides and opiate receptors, in: Basic Neurochemistry (G. J. Seigel, R. W. Albers, B.W. Agaranoff, and R. Katzman, eds.), Little, Brown, Boston, p. 255.Google Scholar
  50. Smith, E. M., and Blalock, J. E., 1981, Human lymphocyte production of ACTH and endorphin-like substances: Association with leukocyte interferon, Proc. Natl. Acad. Sci. U.S.A. 78:7530–7534.PubMedCrossRefGoogle Scholar
  51. Smith, E. M., Meyer, W. J., and Blalock, J. E., 1982, Virus-induced increases in corticosterone in hypophysectomized mice: A possible lymphoid-adrenal axis, Science 218:1311–1312.PubMedCrossRefGoogle Scholar
  52. Smith, E. M., Phan, M., Coppenhaver, D., Kruger, T. E., and Blalock, J. E., 1983, Human lymphocyte production of immunoreactive thyrotropin, Proc. Natl. Acad. Sci. U.S.A. 80:6010–6013.PubMedCrossRefGoogle Scholar
  53. Smith, E. M., Morrill, A. C., Meyer, W. J., and Blalock, J. E., 1986, Corticotropin releasing factor induction of leukocyte derived immunoreactive ACTH and endorphins, Nature (in press).Google Scholar
  54. Stein, M., 1985, Bereavement, depression, stress and immunity, in: Neural Modulation of Immunity (R. Guillemin, M. Cohn, and T. Melnechuk, eds.), Raven Press, New York, pp. 29–41.Google Scholar
  55. Tyrey, L., and Nalbandov, A. V., 1972, Influence of anterior hypothalamic lesions on circulating antibody titers in the rat, Am. J. Physiol. 222:179–185.PubMedGoogle Scholar
  56. Van Epps, D., and Saland, L., 1984, β-Endorphin and met-enkephalin stimulate human peripheral blood mononuclear cell chemotaxis, J. Immunol. 132:3046–3053.PubMedGoogle Scholar
  57. Van Wyk, J. J., Dugger, G. S., Newsome, J. F., and Thomas, P. Z., 1960, The effect of pituitary stalk section in the adrenal function of women with cancer of the breast, J. Clin. Endocrinol. Metab. 20:157–172.CrossRefGoogle Scholar
  58. Wybran, J., 1985, Enkephalins and endorphins as modifiers of the immune system, Fed. Proc. 44:92–94.PubMedGoogle Scholar
  59. Wybran, J., Appelbroom, T., Famaey, J.-P., and Govaerts, A., 1979, Suggestive evidence for receptors for morphine and methionine-enkephalin on normal blood T lymphocytes, J. Immunol. 123:1068–1070.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • Kenneth L. Bost
    • 1
  • Eric M. Smith
    • 1
  • J. Edwin Blalock
    • 1
  1. 1.Department of MicrobiologyUniversity of Texas Medical BranchGalvestonUSA

Personalised recommendations